The CDC has encouraged the liberal use of “existing telehealth tools” in response to the coronavirus pandemic. As the white label platform powering virtual care for health systems across the country, Zipnosis is committed to being a front-line resource in this pandemic. In this latest vlog I break down our commitment to our customers, the healthcare industry, and patients across the country.
Related Insights.
Regulatory Roundup – July 2022
Interested in the latest legislation affecting the telehealth industry? You’ve come to the right place! Let's take a look at how regulations changed in July. Federal US House Bill 4040 — Connecting Rural Telehealth to the Future Act — Passed Introduced on June 22,...
Asynchronous Telemedicine Protocols for Travel-Related Illnesses
With vacation season in full swing, many people ask how they can prevent unforeseen illnesses from disrupting their travel plans. Zipnosis offers a suite of travel-related protocols that allows health systems to efficiently provide care to patients preparing for...
Paxlovid: Expanding prescribing authority isn’t enough to increase access
This month, the FDA authorized state-licensed pharmacists to prescribe Paxlovid to eligible patients with COVID-19. According to the director for the FDA’s Center for Drug Evaluation and Research, Patrizia Cavazzoni, M.D., this new limited authorization should allow...
Put yourself at the forefront of a revolution.